LOS ANGELES, April 12, 2021 (GLOBE NEWSWIRE) -- The Global DNA Methylation Market is expected to grow at a CAGR of around 13.2 % from 2020 to 2027 and reach the market value of over US$ 2,726.2 Mn by 2027.<\/p>\n
North America holds the largest market share for the global DNA methylation market<\/p>\n
The rapid developments in healthcare infrastructure, the presence of prominent players in this region, and massive R&D investments, North America dominates the DNA methylation market. With increased investment in product and industry R&D, demand for protein expression systems is expected to raise, as many mammalian proteins, including growth hormone, insulin, antibodies, and vaccines, are produced on a large scale. Biopharmaceutical sales have recently surpassed 30% of all new pharmaceutical sales in the country. The United States is the world's largest spender on healthcare research. All of these factors contribute to the expansion of the global DNA methylation market.<\/p>\n
DOWNLOAD SAMPLE PAGES OF THIS REPORT@ https:\/\/www.acumenresearchandconsulting.com\/request-sample\/2562<\/a><\/p>\n Market Dynamics<\/p>\n DNA methylation in metabolic diseases, oncology, and immunology flourish the growth of global market<\/p>\n Oncology is one of the fields in which DNA methylation technology is widely used to develop therapeutic strategies aimed at reversing the transcriptional abnormalities inherent in the cancer epigenome. This disruption of epigenetic modifications, which include DNA methylation and histone modification, leads to changes in gene function or expression as well as cellular transformation, which leads to cancer. DNA methylation aids in the development of inhibitors of DNA methyltransferases and histone deacetylases (HDACs), which have been shown to be clinically effective in cancer treatment, demonstrating the importance of DNA methylation technology in oncology.<\/p>\n VIEW TABLE OF CONTENT OF THIS REPORT@ https:\/\/www.acumenresearchandconsulting.com\/dna-methylation-market<\/a><\/p>\n Segmental Outlook<\/p>\n The global DNA methylation market is segmented based on product, application, technology, and end-user. By product, the market is segmented as enzymes, instruments and consumables, kits, reagents, and bioinformatics tools. Enzymes are further sub segmented into DNA-modifying enzymes, protein-modifying enzymes, and RNA-modifying enzymes. Further, instruments and consumables are sub segmented as next-generation sequencers, qPCR, mass spectrometers, sonicators, and others. Kits is further sub segmented as bisulfite conversion kits, ChIP-sequencing kits, RNA sequencing kits, whole genomic amplification kits, 5-hmC and 5-mC analysis kits, and others. Reagents are further sub segmented as antibodies, buffers, histones, magnetic beads, primers, and among others.<\/p>\n By application, the market is segmented as oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and others. Based on application, the market is segmented as oncology, metabolic diseases, immunology, and others. Based on technology, the market is segregated as DNA methylation, histone modifications, and others. By end-user, the market is segmented as academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs)<\/p>\n Competitive Landscape<\/p>\n Key companies profiled in this report involve Illumina, Inc., Merck Millipore, Abcam plc, Active Motif, Bio-Rad Laboratories, Inc., New England Biolabs, Agilent Technologies, Inc., QIAGEN, Zymo Research, PerkinElmer, Inc., Diagenode, and among others.<\/p>\n Browse Upcoming Market Research Reports@https:\/\/www.acumenresearchandconsulting.com\/forthcoming-reports<\/p>\n Some of the key observations regarding DNA methylation industry include:<\/p>\n INQUIRY BEFORE BUYING@ https:\/\/www.acumenresearchandconsulting.com\/inquiry-before-buying\/2562<\/a><\/p>\n BUY THIS PREMIUM RESEARCH REPORT - https:\/\/www.acumenresearchandconsulting.com\/buy-now\/0\/2562<\/a><\/p>\n Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com<\/a>| +1 407 915 4157<\/p>\n For Latest Update Follow Us:<\/p>\n